Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Chinese Journal of Surgery ; (12): 691-694, 2012.
Article in Chinese | WPRIM | ID: wpr-245806

ABSTRACT

<p><b>OBJECTIVE</b>To study on the efficacy, prognosis and security of high-intensity focused ultrasound (HIFU) combined with transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC).</p><p><b>METHODS</b>Totally 72 HCC patients treated by HIFU from December 2009 to January 2011 were divided into two groups according to treatment methods: 40 cases in HIFU group, 32 cases in TACE + HIFU treatment group (combined group). Then set up a control group include 40 cases treated by only TACE in the same period (TACE group). The improvement of clinical symptoms, AFP, reduce rate of tumor volume, survival rate of 1 year after operation and postoperative complications in front and behind the treatment were analyzed.</p><p><b>RESULTS</b>There was no significant statistical difference on the improvement of clinical symptoms in all these three groups (P > 0.05) after treatment for HCC. There is no significant statistical difference also on reduce rate of tumor volume and decrease rate of AFP in both HIFU group (35.0%, 41.4%) and TACE group (37.5%, 41.9%) (χ² = 0.054, P = 0.816; χ² = 0.002, P = 0.965). Both reduce rate of tumor volume (62.5%) and decrease rate of AFP (72.0%) in combined group were better than HIFU group (χ² = 5.394, P = 0.020; χ² = 5.098, P = 0.024) and TACE group (37.5%, 41.9%) (χ² = 4.448, P = 0.035; χ² = 5.062, P = 0.024). Kaplan-Meier survival curve showed that there was no significant statistical difference on short-term survival rate in the 3 groups. But the long-term survival rate of combined group was better than TACE group and HIFU group.</p><p><b>CONCLUSION</b>TACE combined with HIFU is a effective, safe and noninvasive treatment method to HCC.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma, Hepatocellular , Therapeutics , Chemoembolization, Therapeutic , Combined Modality Therapy , Follow-Up Studies , Liver Neoplasms , Therapeutics , Prognosis , Treatment Outcome , Ultrasound, High-Intensity Focused, Transrectal
2.
Chinese Journal of Hepatology ; (12): 523-526, 2010.
Article in Chinese | WPRIM | ID: wpr-326315

ABSTRACT

<p><b>OBJECTIVE</b>To summarize the clinical experiences in the diagnosis and managements of hepatic veno-occlusive disease (HVOD).</p><p><b>METHODS</b>The clinical and pathologic data of 17 patients with hepatic veno-occlusive disease were analyzed retrospectively.</p><p><b>RESULTS</b>According to the results of imaging examination, clinical data and pathological data, 17 patients HVOD were divided into acute progressive HVOD and chronic HVOD. 2 cases out of the 11 acute progressive cases got improved, 2 cases died after medical treatment and 2 cases died after shunt operation. The 6 chronic HVOD, including 1 case with medical treatment and 5 cases with shunt operation, were cured.</p><p><b>CONCLUSION</b>Liver biopsy was an efficient method for the diagnosis of hepatic veno-occlusive disease. Acute progressive cases of hepatic veno-occlusive disease should be managed with medical treatment and the chronic cases could be treated with shunt surgery if medical treatment were inefficient.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Hepatic Veins , Pathology , Hepatic Veno-Occlusive Disease , Diagnosis , Pathology , Therapeutics , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL